Alphabet, Texas Instruments, CoStar Group And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

-1.20%

-6.42%

-0.41%

-6.57%

-2.13%

Alphatec Holdings, Inc. ATEC	19.72	-1.20%
CoStar Group, Inc. CSGP	63.85	-6.42%
Alphabet Inc. Class A GOOGL	308.01	-0.41%
ImmunityBio Inc Ordinary Shares IBRX	2.21	-6.57%
IDEAYA Biosciences IDYA	33.30	-2.13%

U.S. stock futures traded mixed this morning on Wednesday. Here are some big stocks recording losses in today’s pre-market trading session.

Vicor Corporation (NASDAQ:VICR) shares dipped 20.8% to $42.11 in pre-market trading after reporting results for the third quarter.
Alphatec Holdings, Inc. (NASDAQ:ATEC) shares declined 14.5% to $10.96 in pre-market trading after the company priced underwritten public offering of 14.3 million common shares at $10.50 per share.
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) shares fell 11.9% to $24.01 in pre-market trading after the company announced pricing of public offering.
SunPower Corporation (NASDAQ:SPWR) shares declined 9.5% to $4.49 in pre-market trading as the company Plans to restate financial statements for affected periods in amendments to Form 10-K, Q1 Form 10-Q, and Q2 2023 Form 10-Q, respectively.
CoStar Group, Inc. (NASDAQ:CSGP) shares fell 9.5% to $67.16 in pre-market trading after the company reported worse-than-expected third-quarter sales results and issued FY23 guidance below estimates.
ImmunityBio, Inc. (NASDAQ:IBRX) shares declined 8.3% to $1.65 in pre-market trading after jumping over 25% on Tuesday.
Teladoc Health, Inc. (NYSE:TDOC) shares fell 7% to $16.85 in pre-market trading after the company posted downbeat third-quarter sales and issued weak sales forecast for the current quarter.
Alphabet Inc. (NASDAQ:GOOGL) shares fell 6.8% to $129.42 in pre-market trading. Alphabet reported better-than-expected earnings and sales results for its third quarter, but recorded downbeat performance for its cloud computing unit.
Texas Instruments Incorporated (NASDAQ:TXN) shares fell 5.4% to $138.94 in pre-market trading after the company reported worse-than-expected third-quarter sales results and issued fourth-quarter revenue guidance below estimates.

Now Read This: Why The Fear Level Among US Investors Is Easing

Don’t forget to check out our premarket coverage here

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.